Zomedica Corp. (ZOM) Misses Q2 EPS by 1c

Zomedica Corp. (NYSE: ZOM) reported Q2 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $6.02 million versus the consensus estimate of $7.34 million.

For earnings history and earnings-related data on Zomedica Corp. (ZOM) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Quanex (NX) Tops Q3 EPS by 14c; Offers Guidance
• Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance